Cambridge International Advanced Level
Cambridge International Advanced Level
Cambridge International Advanced Level
BIOLOGY 9700/43
Paper 4 A2 Structured Questions October/November 2015
2 hours
Candidates answer on the Question Paper.
Additional Materials: Answer paper available on request.
Write your Centre number, candidate number and name in the spaces provided at the top of this page.
Write in dark blue or black pen.
You may use an HB pencil for any diagrams or graphs.
Do not use staples, paper clips, glue or correction fluid.
DO NOT WRITE IN ANY BARCODES.
At the end of the examination, fasten all your work securely together. 5
The number of marks is given in brackets [ ] at the end of each question or part
question. 6
Section B
9 or 10
Total
This document consists of 21 printed pages, 2 blank pages and 1 lined page.
DC (LK/FD) 98848/3
© UCLES 2015 [Turn over
2
Section A
Fig. 1.1
W .......................................................................................................................................
X ........................................................................................................................................
Y .................................................................................................................................... [3]
(ii) State two differences between anaerobic respiration in yeast cells and anaerobic
respiration in human muscle cells.
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
..........................................................................................................................................
...................................................................................................................................... [2]
(b) Dinitrophenol (DNP) is a compound used as a herbicide. DNP inhibits respiration by interfering
with the formation of the proton gradient between mitochondrial membranes.
When DNP was added to isolated mitochondria the following observations were made:
• fewer ATP molecules were produced
• more heat energy was released
• the uptake of oxygen remained constant.
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[3]
[Total: 8]
BLANK PAGE
2 A vaccine, NicVAX, is being developed to help people stop smoking tobacco. Injection of NicVAX
into the body causes production of antibody molecules that bind to nicotine.
(a) Outline the immune response that leads to the production of these anti-nicotine antibodies.
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[5]
(b) Mice injected with NicVAX produce B-lymphocytes that mature into cells responsible for the
production of antibody (plasma cells).
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[4]
(c) Tobacco smoking during pregnancy has adverse side-effects on the developing fetus.
An investigation was carried out to find out whether vaccinating pregnant women with NicVAX
might offer some protection for the developing fetus.
Two different monoclonal antibodies, produced in response to NicVAX, were used in this
investigation:
• Nic-IgG
• Nic311.
Nicotine, or nicotine plus one of the monoclonal antibodies, was injected into the maternal
circulation. The concentrations of nicotine in the fetal circulation were measured at intervals.
QLFRWLQH
LQIHWDOFLUFXODWLRQQJFP²
QLFRWLQHFRQFHQWUDWLRQ
QLFRWLQH
1LF
QLFRWLQH
1LFOJ*
WLPHPLQXWHV
Fig. 2.1
(i) With reference to Fig. 2.1, describe the results obtained for nicotine only.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
(ii) Discuss the extent to which these results support the idea that vaccination with NicVAX
could protect the developing fetus of a woman who smokes tobacco.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[3]
(d) State one medical use of monoclonal antibodies, other than their use in producing vaccines.
...................................................................................................................................................
...............................................................................................................................................[1]
[Total: 15]
BLANK PAGE
3 Atlantic salmon, Salmo salar, is one of the most important fish species farmed for human
consumption.
Fig. 3.1
Infectious pancreatic necrosis (IPN) is a serious viral disease currently affecting farmed salmon.
(a) (i) Describe how artificial selection could be used to produce a population of salmon that is
resistant to IPN.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[3]
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
© UCLES 2015 9700/43/O/N/15 [Turn over
10
(b) A laboratory investigation was carried out to compare the artificially selected farmed Atlantic
salmon with farmed salmon that had not been artificially selected.
Three groups of young fish were set up in carefully controlled conditions as follows:
• Group A: artificially selected salmon
• Group B: non-artificially selected salmon
• Group C: non-artificially selected salmon.
During this investigation, only groups A and B were exposed to IPN on day 0.
The percentages of salmon that died (percentage mortality) were calculated and are shown
in Fig. 3.2.
JURXS%
SHUFHQWDJH
PRUWDOLW\
JURXS$
JURXS&
WLPHGD\V
Fig. 3.2
(i) Describe and explain the differences in percentage mortality between groups A and B.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[4]
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[1]
[Total: 10]
There is currently no cure, but symptoms of haemophilia can be treated with a transfusion of a
clotting factor to slow down the bleeding.
(a) State how genetic screening could reduce the number of cases of haemophilia.
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[2]
(b) (i) Some genetic disorders can be treated with gene therapy.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
(ii) Suggest why haemophilia A is a suitable disorder for treatment with gene therapy.
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[1]
(c) Haemophilia A and haemophilia B are caused by mutations in different blood clotting genes,
F8 and F9 respectively. Both disorders have been treated with gene therapy involving the use
of a vector.
(i) Table 4.1 shows the lengths, in kilobases (kb), of the F8 and F9 genes.
Table 4.1
gene length
haemophilia gene
/ kb
A F8 >8
B F9 1.4
With reference to Table 4.1, suggest why gene therapy using the F9 gene has been more
successful than using the F8 gene.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
(ii) Two frequently used vectors in gene therapy are compared in Table 4.2.
Table 4.2
feature vector
adenovirus retrovirus
genetic double-stranded DNA single-stranded RNA
material of
virus
With reference to Table 4.2, explain the advantages and disadvantages of using
adenovirus rather than retrovirus as a vector.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[3]
[Total: 10]
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[3]
(b) To reduce the loss of global biodiversity, areas of habitat have been protected.
Fig 5.1 shows the changes in the total area protected and in global biodiversity from 1965 to
2005, in terrestrial and marine habitats.
terrestrial marine
global 1.2 18 global 1.2 18
total area total area
biodiversity biodiversity
protected protected
/ arbitrary / arbitrary
/ km2 × 106 / km2 × 106
units 0.9 9 units 0.9 9
0.6 0 0.6 0
6 5 75 85 95 05 6 5 75 85 95 05
19 19 19 19 20 19 19 19 19 20
year year
key:
global biodiversity
total area protected
Fig. 5.1
(i) With reference to Fig. 5.1, compare the relationship between total area protected and
global biodiversity in terrestrial and marine habitats:
• between 1970 and 1990
• between 1990 and 2005.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[3]
(ii) Suggest why a smaller area of marine habitats has been protected than of terrestrial
habitats.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
[Total: 10]
© UCLES 2015 9700/43/O/N/15
17
6 (a) One important function of the kidney nephron is selective reabsorption. This involves the
rapid transfer of water across cell surface membranes. The rapid transfer of water requires
the presence of protein channels known as aquaporins.
% & '
- (
+
)
Fig. 6.1
With reference to Fig. 6.1, complete the table by inserting the correct letter for each description.
region where aquaporins are always present in the tubule wall cells but
no glucose transport proteins are present
region where tubule wall cells are modified to produce filtration slits
[4]
(b) (i) The urine of people on different types of diet was analysed.
• people on a low protein diet had a mean urea concentration of 2.40 g dm–3
• people on a high protein diet had a mean urea concentration of 14.76 g dm–3.
Calculate the percentage increase in the concentration of urea between the low and high
protein diets.
(ii) Explain why an increase in the quantity of protein in the diet leads to an increase in the
concentration of urea in the urine.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
[Total: 8]
7 (a) Fig. 7.1 shows the absorption spectra of chlorophyll a and chlorophyll b and a corresponding
action spectrum.
;
DFWLRQVSHFWUXP
FKORURSK\OOE <
UDWHRI SHUFHQWDJH
SKRWRV\QWKHVLV OLJKW
DEVRUSWLRQ
FKORURSK\OOD
ZDYHOHQJWKRIOLJKWQP
Fig. 7.1
(i) Explain why peak X of the action spectrum is higher than peak Y.
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
.......................................................................................................................................[2]
(b) Describe the effects on a plant if its environmental temperature rises well above the usual
temperature range.
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[5]
(c) Complete the following paragraph by using the most suitable words to fill in the gaps.
substance called the stroma which is the site of the Calvin cycle. The stroma contains
enzymes such as ................................. and also sugars, lipids and starch. A chloroplast
can be stacked to form grana. Grana membranes hold photosynthetic pigments so that the
light-dependent stage of photosynthesis can take place. The stroma contains circular
.................................. which codes for some of the chloroplast proteins made by its own small
.................................................. . [4]
[Total: 15]
8 The fruit fly, Drosophila melanogaster, is widely used in genetic research. It has many phenotypic
variants in features such as body colour, wing shape and eye colour.
• vestigial (very short) wings, coded for by the recessive allele of the gene N/n
• ebony (black) body colour, coded for by the recessive allele of the gene G/g.
(a) Using the symbols given, state the possible genotypes of normal-winged, grey-bodied fruit
flies.
...................................................................................................................................................
...............................................................................................................................................[2]
(b) Describe how you would determine the genotype of a normal-winged, grey-bodied fly.
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...................................................................................................................................................
...............................................................................................................................................[3]
(c) One of the genes for eye colour is carried on the X chromosome. This gene has different
alleles coding for:
• red eyes
• orange eyes
• white eyes.
The allele for red eyes (R) is dominant to the allele for orange eyes (o) and dominant to the
allele for white eyes (w). The allele for orange eyes is dominant to that for white eyes.
Using these symbols, draw a genetic diagram to show how a cross between a white-eyed
male fruit fly with a red-eyed female fruit fly will produce male and female offspring that are
either red-eyed or orange-eyed.
[4]
[Total: 9]
Section B
(b) Describe and explain the changes to the uterus during the menstrual cycle. [6]
[Total:15]
10 (a) Outline how hybridisation leads to polyploidy in wheat and how this benefits farmers.
[8]
(b) Discuss the detrimental environmental and economic effects of growing genetically modified
herbicide-resistant oil seed rape. [7]
[Total: 15]
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
© UCLES 2015 9700/43/O/N/15 [Turn over
24
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
..................................................................................................................................................................
Permission to reproduce items where third-party owned material protected by copyright is included has been sought and cleared where possible. Every reasonable
effort has been made by the publisher (UCLES) to trace copyright holders, but if any items requiring clearance have unwittingly been included, the publisher will
be pleased to make amends at the earliest possible opportunity.
To avoid the issue of disclosure of answer-related information to candidates, all copyright acknowledgements are reproduced online in the Cambridge International
Examinations Copyright Acknowledgements Booklet. This is produced for each series of examinations and is freely available to download at www.cie.org.uk after
the live examination series.
Cambridge International Examinations is part of the Cambridge Assessment Group. Cambridge Assessment is the brand name of University of Cambridge Local
Examinations Syndicate (UCLES), which is itself a department of the University of Cambridge.